Aprea Therapeutics
APRE
$5.27
Share price
-3.48%
Change (1 day)
37.24%
Change (1 year)
Categories
EPS for Aprea Therapeutics (APRE)
EPS in 2023 (TTM): -$5.53
According to Aprea Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.53. In 2022 the company made an earnings per share (EPS) of -$97.29 a decrease over its 2021 EPS that were of -$35.00.
EPS history for Aprea Therapeutics from 2019 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$5.53 | -94.32% |
| 2022 | -$97.29 | 177.97% |
| 2021 | -$35.00 | -31.1% |
| 2020 | -$50.80 | 70.91% |
| 2019 | -$29.72 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Amedisys AMED | $0.10 | -101.81% | 🇺🇸 USA |
 Healthcare Services Group HCSG | $0.44 | -107.96% | 🇺🇸 USA |